Has Andreas Kamlot, MD received payments from drug or device companies?

Yes. Drug and device makers reported $540,017 in general payments to Andreas Kamlot, MD across 975 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andreas Kamlot, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andreas Kamlot, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andreas Kamlot, MD

Surgery · Danville, CANPI 1720019748

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $458,950 of the $540,017 with a category attached, or 85.0%. Atricure, Inc. accounts for 98.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $123,022 and has fallen 89.7% since, to $12,667 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$540,017in general payments, 2019–2025

Across 975 payments — averaging $553.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$533K
Edwards Lifesciences$3K
Medtronic$1K
Abiomed$697
Abbott$569
Impulse Dynamics (USA) Inc.$172
plus $735 from 15 others

What the payments were for

Consulting fees$458,95085%
Travel & lodging$61,98311%
Food & beverage$19,0854%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	800	$533,267
Edwards Lifesciences	124	$3,347
Medtronic(2 entities)	12	$1,231
Abiomed	9	$697
Abbott	11	$569
Impulse Dynamics (USA) Inc.	1	$172
BD	1	$129
Heartflow, Inc.	1	$121
Shockwave Medical, Inc	2	$66
Philips North America LLC	1	$58
Baxter Healthcare	2	$56
La Jolla Pharmaceutical Company	2	$50
Convatec Inc.	1	$44
Angiodynamics, Inc.	1	$37
Stryker	1	$32
Amgen	1	$28
Merck	1	$28
Artivion, Inc.	1	$25
Teleflex LLC	1	$23
Saphena Medical, Inc.	1	$19
Octapharma USA, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$329,970
EPI-SENSE GUIDED COAGULATION SYS$156,576
ATRICLIP LAA EXCLUSION SYSTEM$129,682
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS$12,700
SYNERGY ABLATION SYSTEM$5,170
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$2,740
ATRICURE SYNERGY ABLATION SYSTEM$2,173
ISOLATOR SURGICAL ABLATION SYSTEM$1,437
DISSECTOR$1,437
Edwards SAPIEN 3 Transcatheter Heart Valve$931
CoreValve Evolut$846
OPTIMIZER$345
MITRIS RESILIA Mitral Valve$295
PROGEL$129
COREVALVE EVOLUT R$125
KONECT RESILIA$122
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$111

How this compares

$540,017 in reported general payments places this provider in the 95th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024

$278,938

Medicare patients

306

Services billed

782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amiodarone Hcl	23	$261
Mupirocin	14	$97
Prednisone	19	$47
Metoprolol Tartrate	14	$43
Furosemide	11	$10

Paid to pharmacies, not to this prescriber.

Other surgery in Danville

Timothy ChuterSan Francisco$8.8M
Santiago HorganSan Diego$2.8M
Rock LiuHayward$1.6M
David LouriePasadena$1.4M
Andrea PakulaThousand Oaks$1.4M
Siew-Ming LeeFresno$1.3M
Beemen KhalilPalo Alto$1.1M
John LiphamLos Angeles$942K
Alexander NedopilLodi$682K
Barry GardinerSan Ramon$602K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →